In a recent Ophthalmology Times commentary, Laura B. Enyedi, MD, and Ramiro Maldonado, MD, joined colleagues to discuss evolving tools and emerging therapies in pediatric ophthalmology that are improving outcomes for young patients.
The article highlights diagnostic breakthroughs such as handheld OCT, widefield imaging, tele-ophthalmology, and AI-based screening. It also explores innovative amblyopia treatments, including FDA-approved binocular digital therapies that offer new options beyond patching. Strategies for early detection of strabismus in high-risk children and pipeline therapies for inherited retinal disorders, including gene therapy and next-generation technologies, are also discussed.
These advances are reshaping how clinicians diagnose, manage, and treat childhood eye disorders, bringing hope to families and improving vision care for the next generation.